cas 326827-21-8|| where to buy 3-cyclobutyl-1H-pyrazol-5-amine

Nombre del producto:3-cyclobutyl-1H-pyrazol-5-amine

IUPAC Name:3-cyclobutyl-1H-pyrazol-5-amine

Unidad de embalaje	Stock disponible	Precio($)
CM107781-1g	in stock	ǟǎ
CM107781-5g	in stock	ţţĳ

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 326827-21-8 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :326827-21-8; Fórmula molecular:C7H11N3; Punto de fusión:-; Código de sonrisas:NC1=CC(C2CCC2)=NN1; Densidad:

: Número de catálogo:CM107781; Peso molecular:137.19; Punto de ebullición:; Nº Mdl:MFCD11187387; Almacenamiento:2-8°C, protect from light

: Pyrazoles; Pyrazoles are organic compounds of the general formula C3H3N2H. It is a five-membered heterocycle consisting of three carbon atoms and two adjacent nitrogen atoms. As an H-bond-donating heterocycle, pyrazole has been used as a more lipophilic and metabolically more stable bioisomer of phenol. Pyrazoles have attracted more and more attention due to their broad spectrum of action and strong efficacy.; Pyrazone; Custom pyrazone for customers from all over the world are our main business.

: Cyclobutanes; The molecular structure of cyclobutane has four carbon atoms, and its four carbon atoms are not in the same plane, which is the folded conformation of cyclobutane. Cyclobutane itself is not of commercial or biological interest, but more complex derivatives are important in biology and biotechnology. Currently, nine FDA-approved drugs contain the cyclobutane structure. From the perspective of therapeutic areas, cyclobutyl drugs are mainly distributed in popular areas such as tumors, neurological diseases, infectious diseases, endocrine and metabolic diseases.